DE602005020761D1 - R rna in einem zellfreien system sowie identifizierung von inhibitoren der rna-synthese - Google Patents

R rna in einem zellfreien system sowie identifizierung von inhibitoren der rna-synthese

Info

Publication number
DE602005020761D1
DE602005020761D1 DE602005020761T DE602005020761T DE602005020761D1 DE 602005020761 D1 DE602005020761 D1 DE 602005020761D1 DE 602005020761 T DE602005020761 T DE 602005020761T DE 602005020761 T DE602005020761 T DE 602005020761T DE 602005020761 D1 DE602005020761 D1 DE 602005020761D1
Authority
DE
Germany
Prior art keywords
rna
rnas
newly
cell
free system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005020761T
Other languages
German (de)
English (en)
Inventor
Mingjun Huang
Yongnian Sun
Wengang Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Achillion Pharmaceuticals Inc
Original Assignee
Achillion Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Achillion Pharmaceuticals Inc filed Critical Achillion Pharmaceuticals Inc
Publication of DE602005020761D1 publication Critical patent/DE602005020761D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/706Specific hybridization probes for hepatitis
    • C12Q1/707Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24211Hepacivirus, e.g. hepatitis C virus, hepatitis G virus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
DE602005020761T 2004-03-24 2005-03-23 R rna in einem zellfreien system sowie identifizierung von inhibitoren der rna-synthese Expired - Lifetime DE602005020761D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55576504P 2004-03-24 2004-03-24
PCT/US2005/009959 WO2005095655A1 (en) 2004-03-24 2005-03-23 Quantitative assay for detection of newly synthesized rna in a cell-free system and identification of rna synthesis inhibitors

Publications (1)

Publication Number Publication Date
DE602005020761D1 true DE602005020761D1 (de) 2010-06-02

Family

ID=34963570

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005020761T Expired - Lifetime DE602005020761D1 (de) 2004-03-24 2005-03-23 R rna in einem zellfreien system sowie identifizierung von inhibitoren der rna-synthese

Country Status (8)

Country Link
US (1) US7985541B2 (https=)
EP (1) EP1735470B1 (https=)
JP (1) JP2007530049A (https=)
AT (1) ATE465276T1 (https=)
CA (1) CA2560699A1 (https=)
DE (1) DE602005020761D1 (https=)
ES (1) ES2345053T3 (https=)
WO (1) WO2005095655A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2901807B1 (fr) * 2006-05-30 2013-08-23 Univ Victor Segalen Bordeaux 2 Nouveau traitement d'une infection par le vhc
US20100062946A1 (en) * 2008-09-08 2010-03-11 Lis John T Genome-wide method for mapping of engaged rna polymerases quantitatively and at high resolution
CN109790143A (zh) 2016-05-10 2019-05-21 C4医药公司 用于靶蛋白降解的胺连接的c3-戊二酰亚胺降解决定子体
EP3454856B1 (en) 2016-05-10 2024-09-11 C4 Therapeutics, Inc. Heterocyclic degronimers for target protein degradation
CN109641874A (zh) 2016-05-10 2019-04-16 C4医药公司 用于靶蛋白降解的c3-碳连接的戊二酰亚胺降解决定子体
ES2990061T3 (es) 2016-05-10 2024-11-28 C4 Therapeutics Inc Degronímeros espirocíclicos para la degradación de proteínas diana
CN110769822A (zh) 2017-06-20 2020-02-07 C4医药公司 用于蛋白降解的n/o-连接的降解决定子和降解决定子体

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT281862B (de) * 1968-07-11 1970-06-10 Robugen Gmbh Verfahren zur Herstellung von neuen 2'-Desoxyuridinen
US5614403A (en) * 1994-06-01 1997-03-25 Baylor College Of Medicine In vitro replication system capable of rescuing cloned and manipulated rotavirus genes
JPH08154687A (ja) * 1994-12-12 1996-06-18 Yamanouchi Pharmaceut Co Ltd アンチセンスオリゴヌクレオチド及び抗ウイルス剤
IT1278077B1 (it) * 1995-05-25 1997-11-17 Angeletti P Ist Richerche Bio Metodologia per riprodurre in vitro le attivita' di rna polimerasi rna-dipendente e di nucleotidiltransferasi terminale codificate dal
US5770370A (en) * 1996-06-14 1998-06-23 David Sarnoff Research Center, Inc. Nuclease protection assays
US20030004122A1 (en) * 1997-11-05 2003-01-02 Leonid Beigelman Nucleotide triphosphates and their incorporation into oligonucleotides
US6004754A (en) * 1998-01-21 1999-12-21 Becton Dickinson And Company DNA sequence, related probes and primers for the detection of Streptococcus agalactiae
WO2000033635A2 (en) * 1998-12-10 2000-06-15 Eli Lilly And Company Primer-independent rna synthesis catalyzed by hcv polymerase
AU2405300A (en) * 1999-01-05 2000-07-24 Advanced Research And Technology Institute, Inc. Uses of flavivirus rna-dependent rna polymerases
DE19915178A1 (de) * 1999-04-03 2000-10-05 Univ Mainz Johannes Gutenberg Hepatitis C Virus Zellkultursystem
EP1111040A1 (en) * 1999-12-10 2001-06-27 Daniel Favre Infection of eukaryotic cells with viruses in vitro
US6447994B1 (en) * 2000-06-20 2002-09-10 The General Hospital Corporation Production of replicative hepatitis C virus

Also Published As

Publication number Publication date
EP1735470B1 (en) 2010-04-21
US20070141558A1 (en) 2007-06-21
ES2345053T3 (es) 2010-09-14
ATE465276T1 (de) 2010-05-15
CA2560699A1 (en) 2005-10-13
JP2007530049A (ja) 2007-11-01
US7985541B2 (en) 2011-07-26
EP1735470A1 (en) 2006-12-27
WO2005095655A1 (en) 2005-10-13

Similar Documents

Publication Publication Date Title
SI1685243T1 (sl) Imortalizirane ptičje celične linije za produkcijo virusov
WO2008033466A3 (en) Compositions and methods for treatment of viral diseases
DE602006015642D1 (de) Hcv-replikationshemmer
WO2006071563A3 (en) Non-tumorigenic mdck cell line for propagating viruses
DE60322880D1 (de) Einfache katalytische dna-biosensoren für ionen auf grundlage von farbveränderungen
EP1735465A4 (en) Compositions for use in identification of viral hemorrhagic fever viruses
ATE466932T1 (de) Vermehrung von viren in zellkultur
WO2004081186A3 (en) Single nucleotide polymorphisms associated with stenosis, methods of detection and uses thereof
EP1513958A4 (en) Compositions and methods for detecting hepatitis b virus
MX2011007693A (es) Metodos para amplificar acidos nucleicos del virus de hepatitis c.
EA201000948A1 (ru) Ингибиторы вирусной полимеразы
ITRM20050067A1 (it) Metodo per la rivelazione di acidi nucleici virali o di origine virale nelle urine.
AU2007240448A8 (en) Methods and compositions for expressing negative-sense viral RNA in canine cells
WO2009001224A3 (en) Antivirals
ATE481494T1 (de) Von rna viren abgeleitetes pflanzenexpressionssystem aus zwei komponenten
WO2009057829A3 (en) Nucleic acid primer set for detection of drug-resistant strain of hepatitis b virus, assay kit, and method of detecting drug-resistant strain of hepatitis b virus
DE602005020761D1 (de) R rna in einem zellfreien system sowie identifizierung von inhibitoren der rna-synthese
EA200401207A1 (ru) Способ обнаружения и определения типа папилломавируса человека с использованием амплификации-гибридизации
WO2003106641A3 (en) IDENTIFICATION OF OLIGONUCLEOTIDES FOR CAPTURE, DETECTION AND QUANTIFICATION OF NUCLEIC ACIDS FROM HEPATITIS A VIRUS
EP2402465A3 (en) Compositions and methods for detection of Hepatitis A virus nucleic acid
ATE441728T1 (de) Mit cmv-resistenz assoziierter molekularer marker und verwendung davon
WO2007076493A3 (en) Methods and reagents for genotyping hcv
WO2006038129A3 (en) Hepatitis c virus replication system
EA200401362A1 (ru) Антивирусная терапия, основанная на противодействии рнк
ATE305522T1 (de) Nachweis von humanen papillomviren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition